Acoustic Neuroma Clinical Trial
Official title:
Acoustic Neuroma: Assessing the Quality of Life by the Scale PANQOL of Patients Operated or Supervised
This study has investigated the quality of life of patients with vestibular schwannoma using this specific scale prospectively, whether treated surgically or monitored.
The PANQOL scale (Penn Acoustic Neuroma Quality-of-Life) is a specific questionnaire
containing 26 items Interviewing 7 areas: hearing, balance, facial expression, anxiety,
vitality, pain, and 'general health. The score is encrypted from 0 to 100, and the highest
score is a reflection of the best possible quality of life. This score has been translated
from French into English and validated according to the reverse translation rules by usual
Oddon et al.
Three questions for this score were added, evaluating quality of life parameters that seem
particularly interesting: the first regarding the difficulties in driving, the second
questioning the recovery of a "normal" life, and the third assessing difficulties in working
life.
The questionnaires are sent to the patient in the form of a custom web link generated on the
online survey platform SurveyMonkey, and integrated into the body of an email sent from the
mailbox of the investigator Hospital. There is any identifying or indirectly identifying data
on the questionnaire online, guaranteeing protection of the rights of the individual. Only
the principal investigator and co-investigator retain the link between the coded identity of
persons undergoing research used to associate personal health data and their name (s) and
name (s) (correspondence table retained securely to the paper).
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT01199978 -
Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma
|
Phase 2 | |
| Recruiting |
NCT06322342 -
Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent
|
Phase 2 | |
| Completed |
NCT00863122 -
Concentration and Activity of Lapatinib in Vestibular Schwannomas
|
Early Phase 1 | |
| Recruiting |
NCT03079999 -
Study of Aspirin in Patients With Vestibular Schwannoma
|
Phase 2 | |
| Completed |
NCT03210285 -
WES of NF2-associated in Comparison to Sporadic Vestibular Schwannomas - Correlation With Clinical Data
|
||
| Completed |
NCT04241679 -
Auditory Nerve Test System During Vestibular Schwannoma Resection
|
N/A | |
| Recruiting |
NCT03393689 -
RGD PET/MRI in Sporadic Vestibular Schwannoma
|
Phase 2 | |
| Not yet recruiting |
NCT06112509 -
Evolution of Vestibular Function After Treatment of a Vestibular Schwannoma by Gamma-knife Radio-surgery
|
N/A | |
| Withdrawn |
NCT03057678 -
Evaluating the Pre-Positioning Frame for Robotic Acoustic Neuroma Removal Surgery
|
N/A | |
| Terminated |
NCT02282917 -
Exploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and Meningioma
|
Early Phase 1 | |
| Withdrawn |
NCT03261726 -
Maintaining Cochlear Patency After VIIIth Nerve Surgery
|
N/A |